Bellafill Filler Treatment in London

Progressive volume loss and the deepening of nasolabial folds represent structural changes within dermal tissue, not merely surface concerns. Bellafill, a PMMA-based dermal filler, may help address these changes by providing immediate structural support while contributing to longer-term tissue quality over time.

At our clinic in London, Bellafill filler treatment is considered for patients with moderate to severe facial lines and wrinkles, acne scarring, or diffuse facial volume loss that has not responded sufficiently to shorter-duration hyaluronic acid options. Suitability is assessed individually at consultation rather than assumed from the concern alone.

Bellafill Filler Treatment in London

Consultation and pricing

Treatment suitability, the personalised plan, and final cost are confirmed after consultation and clinical assessment. Pricing reflects individual anatomy, treatment scope, product volume, number of treatment areas, and clinical complexity.

The figures below represent general market guidance only, based on publicly advertised prices reviewed in June 2026 across 10 London clinics. These are not our clinic’s prices and may not account for consultation fees, product volume differences, promotional pricing, technique variation, or individual planning.

London market guide — Bellafill Filler Treatment

  • Single syringe: about £450–£600
  • Two to three syringes: about £850–£1,500
  • Nasolabial fold treatment (per session): about £450–£850
  • Acne scar treatment (per session): about £500–£900
  • Full-face dermal filler protocol: about £900–£1,800

Before and After Bellafill Filler Treatment

In the weeks following Bellafill injection, patients may notice progressive improvement in facial contour, with nasolabial folds appearing less pronounced and cheek structure more defined. Any immediate minor swelling typically settles within a few days, after which results often look more natural.

Deeper structural improvements, including improved support in areas affected by volume loss and a more even distribution of facial fullness, tend to develop gradually. Outcomes reflect individual anatomy, product volume, and the number of sessions completed, and results vary between patients.

Visible improvements patients may commonly report:

What is Bellafill Dermal Filler?

Bellafill is a semi-permanent dermal filler containing 80% purified bovine collagen gel and 20% polymethyl methacrylate (PMMA) microspheres. Unlike hyaluronic acid filler, which is fully absorbed over months, PMMA microspheres remain within the tissue and may contribute to longer-term structural support.

The collagen carrier provides immediate volume at the injection site, while the PMMA component creates a scaffold within the dermis. This dual mechanism distinguishes Bellafill from conventional HA filler formulations and contributes to results that may last considerably longer, with some patients reporting maintained improvement for up to five years.

Because Bellafill contains bovine collagen, a skin test is required prior to treatment to assess for allergic sensitivity. This is a standard prerequisite and forms part of responsible clinical preparation before any procedure of this type.

Key characteristics of Bellafill used in treatment:

  • PMMA microspheres suspended in bovine collagen gel — not a hyaluronic acid filler
  • Provides immediate correction alongside longer-duration structural support
  • Indicated for moderate to severe nasolabial folds and acne scarring in suitable patients
  • Requires a prior skin test due to the bovine collagen component
  • Cannot be dissolved with hyaluronidase — unlike HA filler, not reversible post-injection
  • Administered by injection using a fine cannula or needle, depending on the area

The Bellafill Filler Procedure: Step by Step

01

Initial Consultation

A face-to-face consultation explores your concerns, aesthetic goals, relevant medical history, and clinical suitability. Where prescription products are required, Dr. Ivan provides this assessment.

02

Bellafill Skin Test and Clinical Assessment

The Bellafill skin test is administered at least four weeks before the procedure to rule out bovine collagen sensitivity. The treatment area is simultaneously assessed for condition and suitability.

03

Preparing for Bellafill

Topical numbing cream is applied to the treatment area in advance to minimise procedural discomfort. Any relevant pre-treatment guidance is discussed at this stage.

04

Bellafill Filler Procedure

Bellafill is injected into the identified area using a precise placement technique. Sessions typically take between 30 and 60 minutes, depending on the number of areas and volume used.

05

Aftercare and Recovery Guidance

Specific aftercare instructions are provided at the end of each session. Any bruising, swelling, or tenderness in the treatment area is typically mild and transient.

Procedure time: 30–60 minutes

Recovery: Minimal downtime is typical. Mild redness, tenderness, or swelling may persist for 24 to 72 hours following the procedure.

Benefits of Bellafill Filler Treatment

Bellafill dermal filler may offer a clinically considered option for patients who have found shorter-duration options insufficient for their concerns, particularly where nasolabial folds, volume loss, or acne scarring require more sustained structural support. The longer-lasting nature of the filler means fewer treatment sessions may be needed to maintain improvement over time.

For patients with moderate to severe facial lines and wrinkles or post-inflammatory acne scarring, Bellafill provides an approach that complements longer-term facial aesthetic planning. Results tend to develop progressively, with the full extent of structural improvement becoming apparent several weeks after each injection as the tissue integrates the product.

Its semi-permanent nature requires careful planning and a thorough understanding of the patient’s facial anatomy and goals. The absence of reversibility with hyaluronidase makes practitioner experience and conservative product placement particularly important in achieving balanced, natural-looking outcomes.

Key benefits of Bellafill filler treatment:

Bellafill Treatment Options

Option One: Single-Area Nasolabial Filler Injection

A targeted Bellafill injection focused on moderate to severe nasolabial folds or a defined area of volume loss. Appropriate for patients with a specific localised concern who have completed the required skin test and are assessed as clinically suitable.

Option Two: Multi-Area Dermal Filler Protocol

A broader Bellafill treatment addressing multiple areas of facial volume loss, including the cheek and midface region, in a single session or across two planned appointments. Suited to patients with diffuse signs of ageing requiring coordinated structural support across several facial zones.

Option Three: Combined Bellafill and Acne Scar Treatment

A tailored approach using Bellafill injection to address both acne scar concerns and areas of volume deficit. This combined procedure is appropriate for patients with significant post-inflammatory scarring alongside general facial volume changes, and is planned carefully following full clinical assessment.

Summary of available approaches:

  • Single-area Bellafill for targeted nasolabial fold correction
  • Multi-area dermal filler protocol for diffuse facial volume loss
  • Acne scar treatment with Bellafill in suitable candidates
  • Combination planning alongside cheek filler, chin filler, or jawline filler where clinically appropriate
  • Course-based treatment planning with reassessment between sessions

Why Choose Us?

Angelika brings over eight years of international medical experience to each treatment, combining advanced injection technique with a structured approach to patient safety and clinically grounded outcomes.

Her practice integrates internationally developed methods within UK certification and insurance standards. Bellafill is a semi-permanent cosmetic procedure requiring careful candidate selection, and every treatment plan here is built from individual clinical assessment rather than a standardised package.

Where prescription-only products are clinically required, Dr. Ivan provides the necessary face-to-face consultation and prescribing through a structured and compliant pathway. For treatments such as Bellafill, which cannot be reversed with hyaluronidase, this level of clinical oversight matters.

Individual anatomy, previous filler history, skin condition, and realistic goals are evaluated at each consultation before any filler procedure proceeds.

What distinguishes our approach:

  • Over 8 years of international medical experience informing injection technique and clinical planning
  • Advanced aesthetic practice aligned with UK certification, insurance, and patient safety standards
  • GMC-registered prescribing support from Dr. Ivan where clinically required
  • Personalised treatment planning confirmed through thorough clinical assessment
  • Considered approach to semi-permanent filler — no treatment is carried out without appropriate prior evaluation
  • Bellafill skin test completed as standard before any Bellafill procedure

Disclaimer: Angelika is an aesthetic practitioner, not a medical doctor. Where prescription-only products are clinically appropriate, face-to-face consultation and prescribing are provided by GMC-registered prescriber Dr. Ivan. This treatment is available to patients aged 18 and over.

Frequently Asked Questions

Results from Bellafill dermal filler may persist considerably longer than those from hyaluronic acid-based options. Some patients maintain visible improvement for up to five years following a complete treatment course, though longevity varies depending on individual factors, including skin condition, age, lifestyle, the number of syringes used, and the treatment area addressed. Clinical assessment helps establish realistic expectations before treatment proceeds.

Every dermal filler procedure carries potential risks, and Bellafill requires particular consideration due to its semi-permanent nature. Because it cannot be dissolved with hyaluronidase, incorrect placement or an adverse tissue response cannot be reversed in the same way as HA filler. Potential side effects include bruising, swelling, tenderness, granuloma formation, or delayed tissue reactions. A mandatory skin test reduces allergic risk, and careful practitioner selection is an important aspect of treatment planning.

Bellafill contains purified bovine collagen, which carries a small risk of allergic reaction in susceptible individuals. A Bellafill skin test is administered at least four weeks before the filler procedure to identify any sensitivity before treatment proceeds. This prerequisite is standard practice for Bellafill and forms part of responsible clinical preparation. Patients with a positive skin test are not suitable candidates for this particular treatment.

The appropriate amount of filler depends on the treatment area, the severity of the concerns being addressed, and the goals established during consultation. Nasolabial fold correction may require one to two syringes per session, while a broader multi-area treatment addressing volume loss across several facial regions may involve more. A personalised treatment plan with a clear recommendation on the amount of filler required is confirmed following your clinical assessment.

Discomfort levels vary between individuals and depend on the treatment area. Topical numbing cream is applied in advance to minimise sensation, and the bovine collagen carrier within Bellafill contains lidocaine, which may help reduce discomfort during injection. Most patients describe the procedure as tolerable. Any tenderness at the injection site typically resolves within a few days, and your practitioner will adjust the approach as needed throughout the session.

Bellafill filler treatment is generally associated with minimal downtime. Some patients notice mild redness, swelling, or bruising in the treatment area for 24 to 72 hours following the injection. The risk of bruising is present with any injectable treatment and varies between individuals. Detailed aftercare guidance is provided at the end of each session, and most patients are able to resume normal daily activities within a short period following their appointment.

Bellafill may be appropriate for adults with moderate to severe nasolabial folds, deep facial lines and wrinkles, acne scarring, or facial volume loss that has not been adequately addressed by shorter-duration filler products. Suitability requires a negative Bellafill skin test result and careful evaluation of medical history, previous filler treatment, and individual anatomy. Individuals who are pregnant, breastfeeding, or have certain connective tissue or autoimmune conditions may not be suitable candidates.

Bellafill can be integrated into a broader facial filler treatment plan alongside other cosmetic treatments, depending on individual assessment and clinical suitability. It is sometimes combined with HA filler for lip fillers or tear trough filler, or planned alongside jawline filler or chin filler as part of a coordinated approach to facial balance. Timing and sequencing of any additional treatment are considered carefully during consultation, and your practitioner will advise on the most appropriate strategy for your concerns.